| Primary |
| Gastrooesophageal Reflux Disease |
41.8% |
| Product Used For Unknown Indication |
18.2% |
| Dyspepsia |
12.7% |
| Gastritis |
5.5% |
| Ulcer |
3.6% |
| Anxiety |
1.8% |
| Barrett's Oesophagus |
1.8% |
| Excoriation |
1.8% |
| Gastric Disorder |
1.8% |
| Hiatus Hernia |
1.8% |
| Medical Observation |
1.8% |
| Oesophageal Disorder |
1.8% |
| Oesophagitis |
1.8% |
| Peptic Ulcer |
1.8% |
| Reflux Oesophagitis |
1.8% |
|
| Paraesthesia |
9.7% |
| Vomiting |
9.7% |
| Death |
6.5% |
| Drug Hypersensitivity |
6.5% |
| Drug Ineffective |
6.5% |
| Medication Error |
6.5% |
| Nausea |
6.5% |
| Syncope |
6.5% |
| Weight Decreased |
6.5% |
| Abdominal Discomfort |
3.2% |
| Abdominal Pain Upper |
3.2% |
| Blood Glucose Increased |
3.2% |
| Blood Pressure Increased |
3.2% |
| Breast Cancer In Situ |
3.2% |
| Cardiac Failure Congestive |
3.2% |
| Convulsion |
3.2% |
| Diarrhoea |
3.2% |
| Ear Disorder |
3.2% |
| Fatigue |
3.2% |
| Flatulence |
3.2% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
43.1% |
| Product Used For Unknown Indication |
10.1% |
| Erosive Oesophagitis |
7.3% |
| Restless Legs Syndrome |
6.4% |
| Drug Use For Unknown Indication |
5.5% |
| Hypertension |
4.6% |
| Sleep Disorder |
3.7% |
| Fibromyalgia |
2.8% |
| Helicobacter Infection |
2.8% |
| Blood Cholesterol Increased |
1.8% |
| Gastritis |
1.8% |
| Ill-defined Disorder |
1.8% |
| Immunisation |
1.8% |
| Abdominal Pain Upper |
0.9% |
| Acid Reflux (Esophageal) |
0.9% |
| Cerebrovascular Accident Prophylaxis |
0.9% |
| Constipation |
0.9% |
| Dyspepsia |
0.9% |
| Gastrointestinal Infection |
0.9% |
| Knee Operation |
0.9% |
|
| Renal Cyst |
20.0% |
| Cardiac Disorder |
8.6% |
| Drug Ineffective |
8.6% |
| Weight Decreased |
8.6% |
| Drug Hypersensitivity |
5.7% |
| Somnolence |
5.7% |
| Vitamin D Deficiency |
5.7% |
| Aphthous Stomatitis |
2.9% |
| Chest Discomfort |
2.9% |
| Fatigue |
2.9% |
| Gastric Disorder |
2.9% |
| Gastritis |
2.9% |
| Intentional Drug Misuse |
2.9% |
| Lichen Planus |
2.9% |
| Malaise |
2.9% |
| Nausea |
2.9% |
| Odynophagia |
2.9% |
| Oesophagitis |
2.9% |
| Overdose |
2.9% |
| Pain |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.2% |
| Gastrooesophageal Reflux Disease |
15.7% |
| Drug Use For Unknown Indication |
13.2% |
| Asthma |
6.1% |
| Pain |
5.5% |
| Crohn's Disease |
5.2% |
| Contraception |
3.6% |
| Hypertension |
3.5% |
| Dyspepsia |
3.1% |
| Hypersensitivity |
2.6% |
| Depression |
2.5% |
| Premenstrual Syndrome |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Blood Cholesterol Increased |
2.1% |
| Fibromyalgia |
2.0% |
| Migraine |
1.8% |
| Back Pain |
1.7% |
| Anxiety |
1.6% |
| Blood Cholesterol |
1.5% |
| Thyroid Disorder |
1.3% |
|
| Weight Decreased |
11.0% |
| Pain |
9.3% |
| Vomiting |
7.9% |
| Nausea |
6.6% |
| Pain In Extremity |
6.6% |
| Cholecystitis Chronic |
5.7% |
| Electrocardiogram Qt Prolonged |
5.3% |
| Weight Increased |
4.4% |
| Abdominal Pain |
4.0% |
| Drug Ineffective |
4.0% |
| Pruritus |
4.0% |
| Rash |
4.0% |
| Sinusitis |
4.0% |
| Fibromyalgia |
3.5% |
| Hypersensitivity |
3.5% |
| Product Quality Issue |
3.5% |
| Pyrexia |
3.5% |
| Anaphylactic Reaction |
3.1% |
| Biliary Dyskinesia |
3.1% |
| Fatigue |
3.1% |
|
| Interacting |
| Hypothyroidism |
33.3% |
| Neuralgia |
33.3% |
| Osteoporosis Prophylaxis |
33.3% |
|
| No Therapeutic Response |
60.0% |
| Application Site Erythema |
20.0% |
| Drug Interaction |
20.0% |
|
